← All trials
NCT04705753
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2020
- Primary completion
- Oct 15, 2020
- Completion date
- Oct 15, 2020
- First posted
- Jan 12, 2021
- Last posted
- Jan 12, 2021
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of CreteLead sponsor
- University of CreteReponsible party - principal investigator
- University of CreteOverall official - principal investigator
- Vifor Inc.Collaborator
- Olvos Science SACollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.